Search research articles
Contact Us
Filters
Showing results (101-110 of 156) with videos related to
Page
of 16
Sort By:
Presse Medicale (Paris, France : 1983)
|
May 9, 1987
[Stevens-Johnson syndrome related to cimetidine]
O Talvard, L Fischbein, M Robineau, et al.
Molecular Pharmaceutics
|
March 10, 2023
Discovery of a Non-competitive TNFR1 Antagonist Affibody with Picomolar Monovalent Potency That Does Not Affect TNFR2 Function
Nagamani Vunnam, MaryJane Been, Evan Huber, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
August 3, 2011
All-atom and coarse-grained molecular dynamics simulations of a membrane protein stabilizing polymer
Jason D Perlmutter, William J Drasler, Wangshen Xie, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
April 1, 1988
[Subacute myocarditis as a manifestation of acquired immunodeficiency syndrome]
B Beaudet, R N Sachs, L Fischbein, et al.
Diabete & Metabolisme
|
June 1, 1987
[Comparative value of 24-hour ECG monitoring and standardized maneuvers in the detection and exploration of cardiac autonomic neuropathy in diabetics]
P Valensi, J R Attali, R N Sachs, et al.
Molecular Pharmacology
|
March 1, 1995
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding
M S Choudhary, N Sachs, A Uluer, et al.
Alcohol (Fayetteville, N.Y.)
|
January 1, 1990
Harman (1-methyl-beta-carboline) in blood plasma and erythrocytes of nonalcoholics following ethanol loading
H Rommelspacher, H Damm, S Lutter, et al.
Biophysical Journal
|
May 27, 2008
Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data
Norbert Kucerka, John F Nagle, Jonathan N Sachs, et al.
Natural Product Communications
|
April 17, 2023
Indirubin Inhibits TRAIL-Induced Activation of Death Receptor 5 in Jurkat Cells
Malaney C Young, Nagamani Vunnam, Robyn T Rebbeck, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1995
5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation
B L Roth, E P Palvimaki, S Berry, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 156) with videos related to
Sort By:
Page
of 16
Presse Medicale (Paris, France : 1983)
|
May 9, 1987
[Stevens-Johnson syndrome related to cimetidine]
O Talvard, L Fischbein, M Robineau, et al.
Molecular Pharmaceutics
|
March 10, 2023
Discovery of a Non-competitive TNFR1 Antagonist Affibody with Picomolar Monovalent Potency That Does Not Affect TNFR2 Function
Nagamani Vunnam, MaryJane Been, Evan Huber, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
August 3, 2011
All-atom and coarse-grained molecular dynamics simulations of a membrane protein stabilizing polymer
Jason D Perlmutter, William J Drasler, Wangshen Xie, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
April 1, 1988
[Subacute myocarditis as a manifestation of acquired immunodeficiency syndrome]
B Beaudet, R N Sachs, L Fischbein, et al.
Diabete & Metabolisme
|
June 1, 1987
[Comparative value of 24-hour ECG monitoring and standardized maneuvers in the detection and exploration of cardiac autonomic neuropathy in diabetics]
P Valensi, J R Attali, R N Sachs, et al.
Molecular Pharmacology
|
March 1, 1995
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding
M S Choudhary, N Sachs, A Uluer, et al.
Alcohol (Fayetteville, N.Y.)
|
January 1, 1990
Harman (1-methyl-beta-carboline) in blood plasma and erythrocytes of nonalcoholics following ethanol loading
H Rommelspacher, H Damm, S Lutter, et al.
Biophysical Journal
|
May 27, 2008
Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data
Norbert Kucerka, John F Nagle, Jonathan N Sachs, et al.
Natural Product Communications
|
April 17, 2023
Indirubin Inhibits TRAIL-Induced Activation of Death Receptor 5 in Jurkat Cells
Malaney C Young, Nagamani Vunnam, Robyn T Rebbeck, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1995
5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation
B L Roth, E P Palvimaki, S Berry, et al.
Page
of 16